#35 - Nir Barzilai, M.D.: How to tame aging
The Peter Attia Drive
00:00
MetFormation in Diabetes
The people on maforman had diabetes the control didn't have. They were more obese than the control. But they had significant less mortality, 17 % less mortality in the metforming group. So if you get less mortality with metforming when the set up is diabetes, that really shows that forming has a very important effect in humans as far as aging what was the medium dose of met foreman in those populations? That's it, just a thousand milligrams. Well, they intended more, but the average was about 50 ap,. 15 hundredy, no, thousand milegrap i'm sorry, this is a discussion there.
Transcript
Play full episode
